Our Medical Experts
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a DoctorDelhi/NCR:
Mohali:
Dehradun:
Bathinda:
Mumbai:
Nagpur:
Lucknow:
BRAIN ATTACK:
To Book an Appointment
Call Us+91 92688 80303Acute Respiratory Distress Syndrome (ARDS), a life-threatening condition characterised by severe respiratory failure demands prompt and expert intervention due to its rapid onset and potentially devastating consequences. At Max Hospitals, we understand the gravity of this condition and are committed to providing comprehensive treatment to patients in need. With our team of dedicated experts and state-of-the-art facilities, we offer personalised care and support to guide patients through their journey towards recovery. Our approach combines advanced medical technologies with compassionate care, ensuring the highest standard of treatment for every individual affected by ARDS.
Acute respiratory distress syndrome (ARDS) is a serious lung condition that develops when fluid builds up in the tiny air sacs (alveoli) of your lungs. This fluid buildup prevents the lungs from properly filling with air, making it difficult to breathe and get enough oxygen into the bloodstream. ARDS typically occurs as a response to various underlying conditions, such as pneumonia, sepsis, trauma, or aspiration of gastric contents into the lungs and can be life-threatening, thus requiring immediate medical attention.
Acute respiratory distress syndrome (ARDS) arises from injuries that damage the lungs. These injuries can come from various sources, broadly classified into two categories:
○ Pneumonia (infection within the lungs)
○ Aspiration (inhaling foreign objects like vomit or food)
○ Inhalation of harmful substances (smoke, toxins)
○ Near drowning
○ Contusion (bruising) of the lungs
○ Sepsis (severe infection anywhere in the body)
○ Severe pancreatitis (inflammation of the pancreas)
○ Severe COVID-19
○ Major trauma or surgery
○ Transfusion of a large amount of blood
○ Certain medications
These are some of the leading causes of ARDS. It's important to note that ARDS can also develop in some cases from less common causes or a combination of factors.
ARDS, or Acute Respiratory Distress Syndrome, can occur in anyone, but certain factors may increase the risk of developing the condition. Common risk factors for ARDS include:
The symptoms of ARDS, or Acute Respiratory Distress Syndrome, typically develop rapidly and can vary in severity. Common symptoms include:
It's important to note that the symptoms of ARDS can overlap with those of other respiratory conditions, making diagnosis challenging. If you or someone you know experiences sudden onset of severe difficulty breathing or any of the symptoms mentioned above, seek immediate medical attention as early intervention is crucial for improving outcomes in ARDS.
Diagnosing ARDS typically involves a combination of clinical evaluation, medical history review, physical examination, and various tests. Here's an overview of the diagnostic process:
The healthcare provider will ask about symptoms such as shortness of breath, rapid breathing, and low oxygen levels. They'll also inquire about any underlying conditions or recent events that may have triggered ARDS, such as pneumonia, sepsis, trauma, or aspiration.
The doctor will listen to the lungs with a stethoscope to detect abnormal breath sounds such as crackles and diminished breath sounds, which are common findings in ARDS.
Blood tests are done to assess oxygen levels, carbon dioxide levels, and other markers of inflammation or organ dysfunction.
These tests measure lung function and capacity, but they are not typically performed during the acute phase of ARDS.
Depending on the suspected underlying cause of ARDS, additional tests such as blood cultures, sputum cultures, and tests for specific infections may be ordered.
The diagnosis of ARDS is based on specific criteria, including the degree of hypoxemia (low oxygen levels), bilateral infiltrates on chest imaging, absence of heart failure as the primary cause, and certain physiological criteria related to respiratory function.
Treatment for ARDS typically involves a combination of supportive care measures aimed at maintaining adequate oxygenation and ventilation, addressing the underlying cause, and preventing complications. Here's an overview of the treatment approach for ARDS:
Most patients with ARDS require mechanical ventilation to support their breathing. Ventilator settings are adjusted to maintain adequate oxygenation while minimising ventilator-induced lung injury. Strategies such as low tidal volume ventilation and prone positioning may be used to optimise lung protection and improve oxygenation.
Supplemental oxygen is provided to maintain adequate oxygen levels in the blood. Oxygen delivery may be titrated based on arterial blood gas measurements and pulse oximetry readings.
Fluid balance is carefully monitored and maintained to avoid fluid overload, which can worsen lung function and lead to complications such as pulmonary edema. Diuretics may be used to help manage fluid balance in some cases.
Placing patients in the prone (face-down) position can improve oxygenation by redistributing blood flow and reducing pressure on the lungs. Prone positioning is often used as a supportive therapy in patients with moderate to severe ARDS.
Treatment for ARDS is often provided in an intensive care unit (ICU) setting, and management is individualised based on the severity of the condition, underlying cause, and patient's overall health status. Close monitoring and multidisciplinary care are essential for optimising outcomes in patients with ARDS.
ARDS itself is a serious condition, and complications can arise from the condition or its treatment. Here are some potential complications of ARDS:
Unfortunately, there's no guaranteed way to prevent ARDS entirely. However, some strategies can help reduce the risk of developing severe ARDS:
Early recognition of risk factors and prompt medical attention are crucial in preventing ARDS from progressing to a severe stage.
The prone position, where patients lie on their stomachs, is often utilised in managing ARDS as it can improve oxygenation by optimising ventilation-perfusion matching in the lungs.
Lung healing from ARDS typically involves resolution of inflammation, repair of damaged tissue, and restoration of normal lung function. This process may take weeks to months and can involve therapies to support lung recovery, such as mechanical ventilation, oxygen therapy, and supportive care.
ARDS is relatively uncommon but can occur in critically ill patients with severe infections, trauma, or other underlying medical conditions. It is more prevalent in intensive care unit (ICU) settings, especially among patients with pneumonia, sepsis, or aspiration.
ARDS can develop rapidly, often within hours to days after the onset of the underlying illness or injury. It is characterised by sudden onset of severe respiratory distress and hypoxemia, requiring prompt medical attention and intervention.
The resolution time for ARDS varies depending on factors such as the underlying cause, severity of lung injury, and effectiveness of treatment. While some patients may recover within a few days to weeks, others may experience a more prolonged course requiring weeks to months for resolution.
The survival rate for ARDS varies depending on factors such as the severity of lung injury, presence of underlying medical conditions, and response to treatment. Overall, the mortality rate for ARDS is significant, with reported rates ranging from 20% to 40% or higher in some cases.
While ARDS cannot always be prevented, measures to reduce the risk of predisposing conditions, such as avoiding smoking, preventing infections, managing chronic medical conditions, and optimising perioperative care, may help minimise the risk of developing ARDS.
Yes, the lungs can recover from ARDS with appropriate treatment and supportive care. Many patients experience improvement in lung function and resolution of symptoms over time, although some may experience persistent respiratory impairment or long-term complications.
ARDS and COVID-19 are not the same, but COVID-19 can lead to ARDS in severe cases. ARDS is a syndrome characterised by acute, diffuse lung injury resulting in severe respiratory distress and hypoxemia, whereas COVID-19 is a viral respiratory illness caused by the novel coronavirus SARS-CoV-2.
The survival rate for ARDS in people with COVID-19 varies depending on factors such as age, underlying health conditions, severity of illness, and access to medical care. While some patients with COVID-19-associated ARDS recover with supportive care, others may experience significant morbidity and mortality, especially in cases of severe illness requiring mechanical ventilation and intensive care.
ARDS is typically managed by a multidisciplinary team of healthcare professionals, including pulmonologists, intensivists, critical care nurses, respiratory therapists, and other specialists. Treatment may be provided in intensive care units (ICUs) or specialised respiratory care units.
The target oxygen level for ARDS is typically to maintain arterial oxygen saturation (SaO2) between 88% and 95% or partial pressure of arterial oxygen (PaO2) between 55 and 80 mm Hg. Oxygen therapy is titrated to achieve adequate oxygenation while avoiding oxygen toxicity.
A pulse oximeter can detect hypoxemia, which is a characteristic feature of ARDS. However, the diagnosis of ARDS requires comprehensive clinical assessment, including evaluation of respiratory symptoms, chest imaging, and laboratory tests, in addition to monitoring oxygen saturation levels.
The stages of ARDS are not universally agreed upon by medical professionals, but some healthcare providers describe ARDS as progressing through three overlapping phases:
The outlook for acute respiratory distress syndrome (ARDS) can vary depending on factors such as the underlying cause and severity of lung injury. While ARDS can be life-threatening, many individuals recover with prompt and appropriate medical care. However, some may experience long-term complications, and mortality rates remain significant. Early recognition, aggressive supportive care, and addressing the underlying cause are essential for improving outcomes.
Reviewed By Dr. Vivek Nangia, Principal Director & Head, Pulmonology on 21 May 2024.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a Doctor